[go: up one dir, main page]

DK0666739T3 - Intravenøs opløsning som formindsker protein- og vandtab fra kroppen - Google Patents

Intravenøs opløsning som formindsker protein- og vandtab fra kroppen

Info

Publication number
DK0666739T3
DK0666739T3 DK94900537T DK94900537T DK0666739T3 DK 0666739 T3 DK0666739 T3 DK 0666739T3 DK 94900537 T DK94900537 T DK 94900537T DK 94900537 T DK94900537 T DK 94900537T DK 0666739 T3 DK0666739 T3 DK 0666739T3
Authority
DK
Denmark
Prior art keywords
water loss
intravenous solution
reduces protein
mammal
administered
Prior art date
Application number
DK94900537T
Other languages
English (en)
Inventor
Douglas Wilmore
Original Assignee
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham & Womens Hospital filed Critical Brigham & Womens Hospital
Application granted granted Critical
Publication of DK0666739T3 publication Critical patent/DK0666739T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00Food or edible material: processes, compositions, and products
    • Y10S426/804Low calorie, low sodium or hypoallergic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00Food or edible material: processes, compositions, and products
    • Y10S426/81Energy rations, e.g. emergency rations, survival rations

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DK94900537T 1992-11-06 1993-11-05 Intravenøs opløsning som formindsker protein- og vandtab fra kroppen DK0666739T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/971,623 US5292722A (en) 1992-11-06 1992-11-06 Intravenous solution that diminishes body protein loss
PCT/US1993/010621 WO1994010988A1 (en) 1992-11-06 1993-11-05 An intravenous solution that diminishes body protein loss

Publications (1)

Publication Number Publication Date
DK0666739T3 true DK0666739T3 (da) 2002-04-22

Family

ID=25518618

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94900537T DK0666739T3 (da) 1992-11-06 1993-11-05 Intravenøs opløsning som formindsker protein- og vandtab fra kroppen

Country Status (9)

Country Link
US (1) US5292722A (da)
EP (1) EP0666739B1 (da)
AT (1) ATE211908T1 (da)
AU (1) AU5548894A (da)
DE (1) DE69331465T2 (da)
DK (1) DK0666739T3 (da)
ES (1) ES2171444T3 (da)
PT (1) PT666739E (da)
WO (1) WO1994010988A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649746B1 (en) 1999-05-07 2003-11-18 University Of Virginia Patent Foundation Biological production of stable glutamine, poly-glutamine derivatives in transgenic organisms and their use for therapeutic purposes
US6221910B1 (en) * 1999-07-22 2001-04-24 The University Of New Mexico Glutamine containing oral replacement solution
CA2399500A1 (en) * 2000-02-01 2001-08-09 Muscletech Research And Development Inc. Alpha lipoic acid based food supplement for increasing lean muscle mass and strength
US6423349B1 (en) 2000-08-24 2002-07-23 Baxter International, Inc. Therapeutic nutrient composition for pre and post elective surgery
US20030099722A1 (en) * 2001-10-09 2003-05-29 Baxter Jeffrey H. Methods and compositions for providing glutamine
US7323206B1 (en) 2003-03-04 2008-01-29 B. Braun Medical Inc. Reagents and methods for all-in-one total parenteral nutrition for neonates and infants
EP1874238A2 (en) * 2005-04-29 2008-01-09 Wyeth Drug delivery devices and related components, systems and methods
US7566463B2 (en) * 2006-05-03 2009-07-28 C. B. Fleet Company Oral rehydration compositions
CA2662847A1 (en) * 2006-09-07 2008-03-13 Wyeth Bone cement mixing systems and related methods
WO2016122791A1 (en) * 2015-01-30 2016-08-04 The Regents Of The University Of California Spinal subpial gene delivery system
US10688285B2 (en) 2015-01-30 2020-06-23 The Regents Of The University Of California Spinal subpial gene delivery system
JP6949867B2 (ja) 2016-03-28 2021-10-13 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California 神経の過剰興奮を治療するための方法および組成物
EP3678709A4 (en) 2017-09-08 2021-06-09 The Regents of the University of California METHOD AND COMPOSITION FOR TREATING NEUROPATHIC PAIN
EP3908198B1 (en) 2019-01-10 2024-12-11 The Regents of the University of California Subpial delivery system
USD963164S1 (en) 2020-01-09 2022-09-06 The Regents Of The University Of California Surgical needle

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1909591A (en) * 1928-06-20 1933-05-16 Novocol Chemical Mfg Co Inc Method of utilizing hypodermic medicaments, etc.
US2283817A (en) * 1941-05-24 1942-05-19 William R Warner & Company Inc Detoxicant
US2662046A (en) * 1948-06-19 1953-12-08 Merck & Co Inc Parenteral amino acid solution
US2868693A (en) * 1956-07-16 1959-01-13 Shive William Peptic ulcer-treating compositions containing glutamine
US3217711A (en) * 1963-08-01 1965-11-16 Abbott Lab Valve apparatus for sequentially administering parenteral fluid from separate sources
US3195778A (en) * 1963-09-17 1965-07-20 Alta Engineering Company Storage and mixing cartridge
GB1125820A (en) * 1965-12-24 1968-09-05 Kyowa Hakko Kogyo Company Ltd The uses of glutamic acid derivatives as preservatives
US3701666A (en) * 1968-02-14 1972-10-31 Morton Norwich Products Inc Process for making amino acid composition
US3574857A (en) * 1968-04-01 1971-04-13 Smith Kline French Lab Antilipidemic methods using glutamic acid,threonine and proline
GB1256162A (en) * 1968-08-16 1971-12-08 Braun Fa B Improvements in and relating to liquid products for intravenous administration
US3832465A (en) * 1971-12-09 1974-08-27 H Ghadimi Injectable amino acid composition commensurate to the anabolic need of the body and method of using same
US3988466A (en) * 1973-06-01 1976-10-26 Kyowa Hakko Kogyo Co., Ltd. Prevention of gastric lesions
US3920838A (en) * 1973-09-04 1975-11-18 Flatt Jean Pierre Amino acid therapy
US3982534A (en) * 1975-01-10 1976-09-28 Buckman Thomas P Intravenous administration system
US3950529A (en) * 1975-02-03 1976-04-13 Massachusetts General Hospital Amino acid formulations for patients with liver disease and method of using same
US4200095A (en) * 1977-08-15 1980-04-29 Millipore Corporation Arrangement for intravenous administration or the like
US4265240A (en) * 1979-04-16 1981-05-05 Imed Corporation Apparatus for providing a controlled introduction of intravenous fluid to a patient
JPS56131554A (en) * 1980-03-17 1981-10-15 Kaken Pharmaceut Co Ltd Novel d-glutamic acid derivative, its preparation, and immunizing agent containing said derivative as effective component
US4334535A (en) * 1980-08-12 1982-06-15 Cutter Laboratories, Inc. Conduit device for rapid priming and flow of liquid
EP0052296B1 (en) * 1980-11-12 1984-06-27 Mitsubishi Kasei Corporation Glutamine derivatives usable for curing immune diseases, methods for their preparation and compositions comprising said derivatives
SE8101247L (sv) * 1981-02-26 1982-08-27 Haessle Ab Lekemedelsadministrationsanordning
US4396383A (en) * 1981-11-09 1983-08-02 Baxter Travenol Laboratories, Inc. Multiple chamber solution container including positive test for homogenous mixture
DE3206784C2 (de) * 1982-02-25 1985-05-09 Pfrimmer & Co Pharmazeutische Werke Erlangen Gmbh, 8520 Erlangen Glutaminhaltige Zubereitungen für orale oder intravenöse Applikation
GB8300011D0 (en) * 1983-01-04 1983-02-09 Fujisawa Pharmaceutical Co Glutamic acid derivatives
US4857555A (en) * 1985-09-12 1989-08-15 Brigham & Women's Hospital Method of treating catabolic dysfunction
US5039704A (en) * 1985-09-12 1991-08-13 Brigham And Women's Hospital Method of treating catabolic dysfunction
SE8902544L (sv) * 1989-07-17 1991-01-18 Kabivitrum Ab Beredning foer naeringstillfoersel, samt saett foer dess framsaellning
SE9003844L (sv) * 1990-12-03 1992-06-04 Kabi Pharmacia Ab Naeringstillsats

Also Published As

Publication number Publication date
WO1994010988A1 (en) 1994-05-26
DE69331465D1 (de) 2002-02-21
EP0666739A1 (en) 1995-08-16
DE69331465T2 (de) 2002-11-07
AU5548894A (en) 1994-06-08
US5292722A (en) 1994-03-08
PT666739E (pt) 2002-05-31
ES2171444T3 (es) 2002-09-16
EP0666739A4 (en) 1996-02-28
EP0666739B1 (en) 2002-01-16
ATE211908T1 (de) 2002-02-15

Similar Documents

Publication Publication Date Title
DK0666739T3 (da) Intravenøs opløsning som formindsker protein- og vandtab fra kroppen
KR940005285A (ko) 염증성 장 질환, 염증성 피부 질환 및 자반증의 예방 및 치료용 약제제조를 위한 상보적 억제제의 용도
CA2113995A1 (en) Use of gentisic acid or gentisyl alcohol for stabilising radiolabeled peptides and proteins
RU93047799A (ru) Композиции, содержащие ретиноевые кислоты и токоферол
CS653586A3 (en) Pharmaceutical containing 7-isopropoxyisoflavone
FI941771A0 (fi) Tehostettu ihonläpäisyjärjestelmä lääkeaineiden parannettua paikallista antoa varten
KR890004709A (ko) 항원충제로서의 아지트로마이신 및 이의 유도체
LV10183A (lv) Perorala kompozicija zarnu iekaisuma slimibu arstesanai
FR2377154A1 (fr) Insecticide contre les poux
ATE147981T1 (de) Verabreichung von lamotrigin zur behandlung von neuro-aids
DE69034070D1 (de) Racemisches Huperzin A
ES2173124T3 (es) Composicion de dermatano sulfato utilizado como antitrombotico.
KR880008801A (ko) 비경구 투여용 용액제
CA2047802A1 (en) Pharmaceutical compositions
WO1991015200A3 (en) Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
FI910112A0 (fi) Preparat foer lokalt bruk.
KR930012023A (ko) 환원된 형태의 비글리코실화 재조합 인체 il2의 안정화된 제약 조성물 및 그의 제조방법
JPS57200361A (en) "indomethacin(r)" pharmaceutical with low irritant action
NO960545D0 (no) Behandling av skadelige virkninger i forbindelse med administrering av ekstracellulært hemoglobin
EP1103269A4 (en) PREPARATIONS FOR THE ADMINISTRATION OF THE HEPATOCYTE GROWTH FACTOR
SE9003181D0 (sv) Use of heparin fraction
JPS55113721A (en) Immunity regulator
JPS6463342A (en) Stabilization of glutathione-containing composition
ATE288282T1 (de) Immunglobulin-infusion bei der xenotransplantation
ES2062332T3 (es) Benzoxazolonas antiinflamatorias.